Evidence map›Paper›PMID 24925219›Full record

ArticlePloS one2014

Sialidase NEU3 dynamically associates to different membrane domains specifically modifying their ganglioside pattern and triggering Akt phosphorylation.

Dario Bonardi, Nadia Papini, Mario Pasini, Loredana Dileo, Flavia Orizio, Eugenio Monti, Luigi Caimi, Bruno Venerando, Roberto Bresciani

Expression of concernOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. GM3 and cancer.Glycoconjugate journal · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dario BonardiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Nadia PapiniDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Mario PasiniDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Loredana DileoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Flavia OrizioDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Eugenio MontiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Luigi CaimiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Bruno VenerandoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Roberto BrescianiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
University of Brescia · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid rafts are known to regulate several membrane functions such as signaling, trafficking and cellular adhesion. The local enrichment in sphingolipids and cholesterol together with the low protein content allows their separation by density gradient flotation after extraction with non-ionic detergent at low temperature. These structures are also referred to as detergent resistant membranes (DRM). Among sphingolipids, gangliosides play important roles in different biological events, including signal transduction and tumorigenesis. Sialidase NEU3 shows high enzymatic specificity toward gangliosides. Moreover, the enzyme is present both at the cell surface and in endosomal structures and cofractionates with caveolin. Although changes in the expression level of NEU3 have been correlated to different tumors, little is known about the precise distribution of the protein and its ability in modifying the ganglioside composition of DRM and non-DRM, thus regulating intracellular events. By means of inducible expression cell system we found that i) newly synthesized NEU3 is initially associated to non-DRM; ii) at steady state the protein is equally distributed between the two membrane subcompartments, i.e., DRM and non-DRM; iii) NEU3 is degraded via the proteasomal pathway; iv) the enzyme specifically modifies the ganglioside composition of the membrane areas where it resides; and v) NEU3 triggers phosphorylation of Akt, even in absence of exogenously administered EGF. Taken together our data demonstrate that NEU3 regulates the DRM ganglioside content and it can be considered as a modulator of Akt phosphorylation, further supporting the role of this enzyme in cancer and tumorigenesis.

Indexed as

AnimalsDetergentsExtracellular Signal-Regulated MAP KinasesGangliosidesGreen Fluorescent ProteinsHeLa CellsHumansLeupeptinsMembrane MicrodomainsMiceNeuraminidasePhosphorylationProteasome Endopeptidase ComplexProteolysisProto-Oncogene Proteins c-aktbenzyloxycarbonylleucyl-leucyl-leucine aldehydeDetergentsExtracellular Signal-Regulated MAP KinasesGangliosidesGreen Fluorescent ProteinsLeupeptinsNeu3 protein, mouseNeuraminidaseProteasome Endopeptidase ComplexProto-Oncogene Proteins c-akt

Identifiers

PMID24925219
PMCPMC4055604
OpenAlexW2081757879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.